2-Naphthacenecarboxamide, 1,3,10,11,12-pentahydroxy-6-methyl- (2602-31-5)

Identification
Name:	2-Naphthacenecarboxamide, 1,3,10,11,12-pentahydroxy-6-methyl-
CAS:	2602-31-5
Molecular Formula:	C₂₀H₁₅NO₆
Molecular Structure:
Properties
Safety Data

Other Product

2-Naphthacenecarboxamide,1,3,10,11,12-pentahydroxy-
Spiro[2-cyclohexene-1,2'(1'H)-cyclopenta[de]naphthacene]-9'-carboxamide,6'-(b-D-glucopyranosyloxy)-7',7'a,8',11',11'a,12'-hexahydro-5',7'a,10',11'a,12'-pentahydroxy-3'-methoxy-2,6,6-trimethyl-7',8'-dioxo-,[2'S-(2'a,7'ab,11'ab,12'b)]- (9CI)
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-piperazinylmethyl)-,hydrochloride (7CI,8CI)
2-Naphthacenecarboxamide,1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,(4aS,5aS,6S,12aS)-
2-Naphthacenecarboxamide,4-(dimethylamino)-6-[(hexylthio)methyl]-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-1,11-dioxo-
2-Naphthacenecarboxamide,6-[(decylthio)methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-1,11-dioxo-
2-Naphthacenecarboxamide,6-[(butylthio)methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-1,11-dioxo-
2-Naphthacenecarboxamide,4-(dimethylamino)-6-[(ethylthio)methyl]-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-1,11-dioxo-
2-Naphthacenecarboxamide,6-[[(dihydroxypropyl)thio]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-1,11-dioxo-
1/C12H9NO/c14-9-11-3-1-2-4-12(11)10-5-7-13-8-6-10/h1-9
2-Naphthacenecarboxamide,N-[[4-[amino[(aminoiminomethyl)imino]methyl]-1-piperazinyl]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,(4S,4aS,5aS,6S,12aS)-
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-N-[[4-(2-hydroxyethyl)-1-piperazinyl]methyl]-6-methyl-1,11-dioxo-,(4S,4aS,5aS,6S,12aS)-
2-Naphthacenecarboxamide,N-[2-cyano-1-methylene-2-(4-methylphenyl)propyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrate (1:1), (4S,4aR,5S,5aR,6R,12aS)-
l-Proline, 5-oxo-, compd. with (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrate (1:1), (4S,4aS,5aS,6S,12aS)-
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrochloride (1:1), (4R,4aS,5aS,6S,12aS)-
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,calcium salt (1:2), (4S,4aR,5S,5aR,6R,12aS)-
1/C12H17NO2/c14-11-4-2-1-3-9(11)7-10-8-12(5-6-12)15-13-10/h9H,1-8H
2-Naphthacenecarboxamide,6-[[(3-chloropropyl)thio]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-1,11-dioxo-,[4S-(4a,4aa,5a,5aa,6a,12aa)]- (9CI)